Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bazedoxifene adjunctive treatment for schizophrenia in men
ACTRN12619001471178Phase 2Recruiting
- Sponsor
- Monash University Foundation
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in schizophrenia comparing Bazedoxifene adjunctive arm with Placebo adjunctive arm (2 arms). Primary endpoint: Change in psychopathology scores. Started Nov 2019; status: recruiting.
02
Drugs
bazedoxifene
03
Conditions
schizophrenia
Beyond the preview
Go deeper on ACTRN12619001471178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619001471178.